MedTrace Logo

A Non-interventional, Observational Study for Quality of Life (Overall Health Assessment) in Patients With Chronic Severe Pain During Targinact® Treatment

NCT01710917 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2013-11-13

No results posted yet for this study

Summary

This non-interventional, observational study evaluates the efficacy of Targinact with regard to quality of life in daily clinical practice in Belgium compared to the previous analgesic treatment.

Conditions

  • Chronic Severe Pain

Interventions

DRUG

Targinact® (oxycodon/naloxon)

Sponsors & Collaborators

  • Mundipharma CVA

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-11-30
Completion
2014-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01710917 on ClinicalTrials.gov